Tigecycline for the treatment of severe CDiff
-
- Long Time Contributor
- Posts: 2635
- Joined: Sat Sep 12, 2015 10:07 am
Tigecycline for the treatment of severe CDiff
Four patients with successful treatment of severe refractory CDI with intravenous tigecycline. All of the patients had the following severity markers recently reviewed: leukocytosis, elevated creatinine level, elevated lactate level, hypoalbuminemia, fever, and signs of severe colitis. Previous standard therapy had failed for 3 of the 4 patients, whereas 1 patient was treated primarily with tigecycline. In all cases, the symptoms of CDI subsided within 1 week after initiation of treatment with tigecycline. In 3 of the 4 patients, a colectomy was considered. After initiation of tigecycline therapy, all patients recovered quickly, and surgery was no longer indicated. Tigecycline is a broad-spectrum, intravenous antimicrobial approved for the treatment of complicated skin and soft-tissue infections and complicated abdominal infections.
-
- Contributor
- Posts: 96
- Joined: Tue Nov 17, 2015 2:53 pm
Re: Tigecycline for the treatment of severe CDiff
Hello Georgina. I read about that study. Not sure if its the same one but I saw it was from 2011. I'm wondering if it is still being pursued or if things have subsided now that FMT's are becoming more common as a treatment for recurring C diff.
Who is online
Users browsing this forum: No registered users and 53 guests